XML 18 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net (loss)/income $ (408,223) $ 10,277,340
Adjustments to reconcile net (loss)/income to net cash used in operating activities:    
Depreciation and other amortization 135,308 138,471
Stock-based compensation 902,280 1,130,010
Deferred income taxes, net (277,850) 36,450
Changes in assets and liabilities:    
Accounts receivable 13,980,644 3,003,771
Inventory (9,496,799) 1,512,118
Prepaid expenses and other assets (175,802) 239,518
Accounts payable, accrued expenses and other liabilities 10,409,997 (3,468,684)
Income tax payable (8,007,679) (18,987,210)
Net cash provided by/(used in) operating activities 7,061,876 (6,118,216)
Cash flows from investing activities:    
Capital expenditures (24,893) 0
Cash used in investing activities (24,893) 0
Cash flows from financing activities:    
Payment of employee tax obligations for common stock tendered (166,193) (158,980)
Cash used in financing activities (166,193) (158,980)
Net increase/(decrease) in cash and cash equivalents 6,870,790 (6,277,196)
Cash and cash equivalents at the beginning of period 155,400,262 150,145,844
Cash and cash equivalents at end of period 162,271,052 143,868,648
Supplemental disclosure of non-cash financing activities:    
Issuance of common stock $ 0 $ 417,000